| Authors: |
Digles D; Department of Pharmaceutical Sciences, University of Vienna, Vienna, Austria., Ingles-Prieto A; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Dvorak V; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Mocking TAM; Division of Drug Discovery and Safety, LACDR, Leiden University, Leiden, Netherlands., Goldmann U; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Garofoli A; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Homan EJ; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Di Silvio A; Axxam SpA, Bresso, Italy., Azzollini L; Axxam SpA, Bresso, Italy., Sassone F; Axxam SpA, Bresso, Italy., Fogazza M; Axxam SpA, Bresso, Italy., Bärenz F; Sanofi, Integrated Drug Discovery, Industriepark Hoechst, Frankfurt am Main, Hessen, Germany., Pommereau A; Sanofi, Integrated Drug Discovery, Industriepark Hoechst, Frankfurt am Main, Hessen, Germany., Zuschlag Y; Sanofi, Integrated Drug Discovery, Industriepark Hoechst, Frankfurt am Main, Hessen, Germany., Ooms JF; Division of Drug Discovery and Safety, LACDR, Leiden University, Leiden, Netherlands., Tranberg-Jensen J; Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., Hansen JS; Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., Stanka J; Lead Identification and Characterization, Bayer Pharmaceuticals, Wuppertal, Germany., Sijben HJ; Division of Drug Discovery and Safety, LACDR, Leiden University, Leiden, Netherlands., Batoulis H; Lead Identification and Characterization, Bayer Pharmaceuticals, Wuppertal, Germany., Bender E; Lead Identification and Characterization, Bayer Pharmaceuticals, Wuppertal, Germany., Martini R; Department of Pharmaceutical Sciences, University of Vienna, Vienna, Austria., IJzerman AP; Division of Drug Discovery and Safety, LACDR, Leiden University, Leiden, Netherlands., Sauer DB; Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., Heitman LH; Division of Drug Discovery and Safety, LACDR, Leiden University, Leiden, Netherlands., Manolova V; CSL Vifor, StGallen, Switzerland., Reinhardt J; Novartis Pharma AG, Basel, Switzerland., Ehrmann A; Lead Identification and Characterization, Bayer Pharmaceuticals, Wuppertal, Germany., Leippe P; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Ecker GF; Department of Pharmaceutical Sciences, University of Vienna, Vienna, Austria., Huber KVM; Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., Licher T; Sanofi, Integrated Drug Discovery, Industriepark Hoechst, Frankfurt am Main, Hessen, Germany., Scarabottolo L; Axxam SpA, Bresso, Italy., Wiedmer T; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Superti-Furga G; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.; Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria. |
